Skip to main content
. 2014 Aug 20;14:105. doi: 10.1186/1471-2261-14-105

Table 2.

Association between individual MetS component and coronary parameters according to diabetes status

Characteristic
n
Any plaque
Obstructive plaque
CACS >100
    OR (95% CI) OR (95% CI) OR (95% CI)
No diabetes
2308
 
 
 
Obesity
 
 
 
 
No
1383
1.00
1.00
1.00
Yes
925
1.27 (1.05–1.55)
1.20 (0.91–1.59)
1.19 (0.88–1.62)
Increased blood pressure
 
 
 
 
No
664
1.00
1.00
1.00
Yes
1644
1.25 (1.01–1.55)
1.59 (1.14–2.23)
1.27 (0.89–1.81)
Increased triglycerides
 
 
 
 
No
1522
1.00
1.00
1.00
Yes
786
1.37 (1.12–1.68)
1.56 (1.18–2.06)
1.18 (0.87–1.62)
Decreased HDL
 
 
 
 
No
1616
1.00
1.00
1.00
Yes
692
1.35 (1.09–1.68)
1.55 (1.14–2.10)
1.57 (1.12–2.19)
Increased fasting glucose
 
 
 
 
No
1640
1.00
1.00
1.00
Yes
668
1.22 (0.99–1.50)
0.97 (0.72–1.31)
1.24 (0.90–1.69)
Type 2 diabetes
561
 
 
 
Obesity
 
 
 
 
No
288
1.00
1.00
1.00
Yes
273
1.27 (0.85–1.90)
0.86 (0.57–1.31)
1.12 (0.72–1.75)
Increased blood pressure
 
 
 
 
No
140
1.00
1.00
1.00
Yes
421
1.03 (0.65–1.63)
0.76 (0.48–1.21)
1.11 (0.66–1.86)
Increased triglycerides
 
 
 
 
No
315
1.00
1.00
1.00
Yes
246
1.34 (0.89–2.02)
1.00 (0.65–1.53)
0.93 (0.59–1.47)
Decreased HDL
 
 
 
 
No
347
1.00
1.00
1.00
Yes 214 0.92 (0.60–1.40) 1.44 (0.93–2.24) 1.13 (0.70–1.82)

All models are adjusted for age, sex, current smoking, LDL, and GFR. CACS, coronary artery calcium score; CI, confidence intervals; GFR, glomerular filtration rate; HDL, high-density lipoprotein; LDL, low-density lipoprotein, MetS, metabolic syndrome; OR, odds ratios. *P <0.001; P <0.01; P <0.05.